Histological heterogeneity of SLFN11 expression and its association with response to carboplatin plus paclitaxel therapy in salivary gland cancer.
BACKGROUND Schlafen family member 11 (SLFN11) has emerged as a potential biomarker of sensitivity to DNA-damaging agents, including platinum compounds. However, its expression profile and clinical significance in salivary gland cancer (SGC) remain poorly understood. This study investigated the histological distribution...